Public Comment

ASTRO posts drafts of clinical practice guidelines, white papers and other documents for public comment before they are finalized and sent to ASTRO's Board of Directors for approval. The public comment period is an integral part of guidance development and is preceded by a series of reviews and revisions and may be followed by a final peer review if the document is submitted to a journal for publication. ASTRO encourages those in the radiation oncology field to comment and then share with colleagues, producing a more robust public response.

ASTRO seeks public comments for first guideline on radiation therapy for Hodgkin lymphoma

ASTRO requests feedback on the draft guideline on Radiation Therapy for Hodgkin Lymphoma. The guideline scope includes the use of radiation therapy in classic and nodular lymphocyte predominant Hodgkin lymphoma in the upfront, combined-modality setting, and in relapsed or refractory disease. Discussions of indications for radiation therapy, techniques, integration with systemic therapy, and strategies to protect organs at risk, and appropriate follow-up and surveillance are also included.

Please review the guideline and submit comments through the webform by Wednesday, June 10.